Coya Therapeutics Inc (NASDAQ: COYA) on Friday, soared 9.38% from the previous trading day, before settling in for the closing price of $6.29. Within the past 52 weeks, COYA’s price has moved between $4.75 and $10.69.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -38.60%. With a float of $15.53 million, this company’s outstanding shares have now reached $16.71 million.
The firm has a total of 8 workers. Let’s measure their productivity. In terms of profitability, gross margin is 99.71%, operating margin of -116.56%, and the pretax margin is -104.41%.
Coya Therapeutics Inc (COYA) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Coya Therapeutics Inc is 7.03%, while institutional ownership is 26.59%. The most recent insider transaction that took place on Nov 14 ’24, was worth 12,934. In this transaction Chief Financial Officer of this company bought 1,800 shares at a rate of $7.19, taking the stock ownership to the 8,800 shares. Before that another transaction happened on Nov 13 ’24, when Company’s Chief Executive Officer bought 5,000 for $7.36, making the entire transaction worth $36,797. This insider now owns 10,000 shares in total.
Coya Therapeutics Inc (COYA) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -38.60% per share during the next fiscal year.
Coya Therapeutics Inc (NASDAQ: COYA) Trading Performance Indicators
Coya Therapeutics Inc (COYA) is currently performing well based on its current performance indicators. A quick ratio of 15.31 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.72, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -1.26 in one year’s time.
Technical Analysis of Coya Therapeutics Inc (COYA)
Analysing the last 5-days average volume posted by the [Coya Therapeutics Inc, COYA], we can find that recorded value of 0.23 million was better than the volume posted last year of 0.1 million. As of the previous 9 days, the stock’s Stochastic %D was 30.52%. Additionally, its Average True Range was 0.64.
During the past 100 days, Coya Therapeutics Inc’s (COYA) raw stochastic average was set at 35.01%, which indicates a significant decrease from 43.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 92.69% in the past 14 days, which was higher than the 89.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.16, while its 200-day Moving Average is $6.58. Now, the first resistance to watch is $7.45. This is followed by the second major resistance level at $8.03. The third major resistance level sits at $8.67. If the price goes on to break the first support level at $6.23, it is likely to go to the next support level at $5.59. Should the price break the second support level, the third support level stands at $5.02.
Coya Therapeutics Inc (NASDAQ: COYA) Key Stats
Market capitalization of the company is 114.96 million based on 16,707K outstanding shares. Right now, sales total 6,000 K and income totals -7,990 K. The company made 3,430 K in profit during its latest quarter, and -2,890 K in sales during its previous quarter.
